ISSN 1004-4140
CN 11-3017/P
梁玉红, 钟溪溪, 姚新群, 等. 糖尿病患者肺部新型冠状病毒感染HRCT特点[J]. CT理论与应用研究, 2023, 32(5): 659-665. DOI: 10.15953/j.ctta.2023.031.
引用本文: 梁玉红, 钟溪溪, 姚新群, 等. 糖尿病患者肺部新型冠状病毒感染HRCT特点[J]. CT理论与应用研究, 2023, 32(5): 659-665. DOI: 10.15953/j.ctta.2023.031.
LIANG Y H, ZHONG X X, YAO X Q, et al. High-resolution Computed Tomography (HRCT) Characteristics of Coronavirus Disease 2019 (COVID-19) in Patients with Diabetes[J]. CT Theory and Applications, 2023, 32(5): 659-665. DOI: 10.15953/j.ctta.2023.031. (in Chinese).
Citation: LIANG Y H, ZHONG X X, YAO X Q, et al. High-resolution Computed Tomography (HRCT) Characteristics of Coronavirus Disease 2019 (COVID-19) in Patients with Diabetes[J]. CT Theory and Applications, 2023, 32(5): 659-665. DOI: 10.15953/j.ctta.2023.031. (in Chinese).

糖尿病患者肺部新型冠状病毒感染HRCT特点

High-resolution Computed Tomography (HRCT) Characteristics of Coronavirus Disease 2019 (COVID-19) in Patients with Diabetes

  • 摘要: 目的:探讨糖尿病患者肺部新型冠状病毒感染(COVID-19)HRCT特点。材料与方法:收集2022年12月14日至2023年1月10日确诊COVID-19且胸部CT表现异常的患者584例,男359例、女225例,年龄范围60~99岁,平均年龄(76±9)岁。其中合并糖尿病225例,非糖尿病359例;比较糖尿病患者COVID-19胸部HRCT与非糖尿病患者COVID-19胸部HRCT表现不同;定义发病与CT检查时间间隔<7d为急性期,363例入组患者,分析急性期糖尿病组与非糖尿病组新型冠状病毒肺炎(COVID-19)HRCT特点。结果:糖尿病患者COVID-19胸部感染与非糖尿病患者COVID-19胸部感染两组肺内病变在发病部位、分布、形态及伴随征象差异无统计学意义。两组病变在密度(细网格、病变密度不均匀)及病变边缘(病变边缘模糊)差异有统计学意义。无糖尿病组的肺部影像网格、不均匀和模糊征象显著高于有糖尿病组。其中细网格影:糖尿病组54例(24%),非糖尿病组127例(35.38%);密度不均匀:糖尿病组181例(80.44%),非糖尿病组313例(87.19%);边缘模糊:糖尿病组205例(91.11%),非糖尿病组344(95.82%)。急性期糖尿病组患者肺内网格影明显少于非糖尿病组患者,糖尿病组35例(24.65%),非糖尿病组82例(37.10%),差异有统计学意义。结论:糖尿病患者肺部新型冠状病毒感染(COVID-19)胸部HRCT病变渗出为主、密度均匀、边缘清晰,较非糖尿病组间质改变不明显。

     

    Abstract: Objective: To explore the characteristics of high-resolution computed tomography (HRCT) in diabetes complicated with coronavirus disease 2019 (COVID-19)-associated pneumonia. Materials and Methods: This study included 584 patients (359 males and 225 females), aged between 60~99 years old (mean, (76±9) years), with positive chest computed tomography (CT) findings and diagnosed with COVID-19 in our hospital from December 14, 2022, to January 10, 2023. Of these, 225 patients were diabetic and 359 were non-diabetic. The features of the chest HRCT from patients with diabetes mellitus complicated with COVID-19 and those without diabetes mellitus complicated with COVID-19 were compared. Moreover, 363 patients in the acute stage of COVID-19 (defined as the time interval between onset and CT examination <7 days) were selected for subgroup analysis, and the HRCT characteristics of COVID-19 between the diabetes group and the non-diabetic group in the acute stage. Results: The location, distribution, morphology, and concomitant signs of pulmonary lesions between the two groups of patients with COVID-19 did not differ significantly. Conversely, statistically significant differences in density (fine mesh, uneven density) and lesion margin (fuzzy lesion margin) were detected. In particular, the grid, uneven, and fuzzy signs on lung imaging were significantly higher in the non-diabetic group than that in the diabetic group. Additionally, 54 patients (24%) in the diabetic group and 127 patients (35.38%) in the non-diabetic group demonstrated fine mesh shadows. There were 181 patients (80.44%) in the diabetic group and 313 patients (87.19%) in the non-diabetic group with uneven density. Furthermore, 205 patients (91.11%) in the diabetic group and 344 patients (95.82%) in the non-diabetic group had blurred edges. There was significantly less pulmonary grid shadowing in the acute subgroup with diabetes (35, 24.65%) than in the acute subgroup without diabetes (82, 37.10%). Conclusion: The features of chest HRCT in patients with diabetes mellitus and COVID-19 are mainly exudation, uniform density, and a clear edge, while the interstitial changes are not obvious compared with patients in the non-diabetic group.

     

/

返回文章
返回